Raffaella Faggioni

Person

Pleasanton, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CCL20 as a predictor of clinical response to IL23-antagonists
- Patent number 11,220,541
- Issue date Jan 11, 2022
- Amgen Inc.
- Robert W. Georgantas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prediction of clinical response to IL23-antagonists using IL23 path...
- Patent number 11,016,099
- Issue date May 25, 2021
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies directed to tumor necrosis factor and uses thereof
- Patent number 8,101,178
- Issue date Jan 24, 2012
- Amgen Fremont Inc.
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fully human monoclonal antibodies to IL-13
- Patent number 7,994,302
- Issue date Aug 9, 2011
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against interleukin-1 β
- Patent number 7,964,193
- Issue date Jun 21, 2011
- Amgen Fremont Inc.
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fully human monoclonal antibodies to IL-13
- Patent number 7,585,500
- Issue date Sep 8, 2009
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against interleukin-1β
- Patent number 7,566,772
- Issue date Jul 28, 2009
- Amgen Fremont Inc.
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to tumor necrosis factor
- Patent number 7,285,269
- Issue date Oct 23, 2007
- Amgen Fremont, Inc.
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...
- Publication number 20220373539
- Publication date Nov 24, 2022
- Amgen Inc.
- Robert W. Georgantas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS
- Publication number 20220144935
- Publication date May 12, 2022
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Application
CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS
- Publication number 20200262907
- Publication date Aug 20, 2020
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Application
PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...
- Publication number 20180252728
- Publication date Sep 6, 2018
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Application
THERAPIES FOR IMPROVING PULMONARY FUNCTION
- Publication number 20130281876
- Publication date Oct 24, 2013
- MEDIMMUNE LIMITED
- Raffaella Faggioni
- G01 - MEASURING TESTING
Information Patent Application
Antibodies against interleukin-1 beta
- Publication number 20100183616
- Publication date Jul 22, 2010
- Amgen Fremont Inc.
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FULLY HUMAN MONOCLONAL ANTIBODIES TO IL-13
- Publication number 20100047253
- Publication date Feb 25, 2010
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF
- Publication number 20080187531
- Publication date Aug 7, 2008
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies against interleukin-1 beta
- Publication number 20070065439
- Publication date Mar 22, 2007
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fully human monoclonal antibodies to IL-13
- Publication number 20060140948
- Publication date Jun 29, 2006
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to tumor necrosis factor and uses thereof
- Publication number 20050049402
- Publication date Mar 3, 2005
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Raffaella Faggioni

Person

Patents Grantslast 30 patents

CCL20 as a predictor of clinical response to IL23-antagonists

Prediction of clinical response to IL23-antagonists using IL23 path...

Antibodies directed to tumor necrosis factor and uses thereof

Fully human monoclonal antibodies to IL-13

Antibodies against interleukin-1 β

Fully human monoclonal antibodies to IL-13

Antibodies against interleukin-1β

Antibodies directed to tumor necrosis factor

Patents Applicationslast 30 patents

PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...

CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS

CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS

PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...

THERAPIES FOR IMPROVING PULMONARY FUNCTION

Antibodies against interleukin-1 beta

FULLY HUMAN MONOCLONAL ANTIBODIES TO IL-13

ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF

Antibodies against interleukin-1 beta

Fully human monoclonal antibodies to IL-13

Antibodies directed to tumor necrosis factor and uses thereof